Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > You know Monday will be exciting..
View:
Post by gojotv! on Nov 14, 2020 3:42pm

You know Monday will be exciting..

...by the presence of bashers on this board ON THE WEEKEND!
Can you smell the money?!
Comment by Rumpl3StiltSkin on Nov 14, 2020 6:02pm
I actually like where TLT is positioned with this Covid 19 play. IF the next study is successful, with the actuall Covid 19 virus, then it should be a big money maker. Not every country will be equipped for the -70deg Cel storage required to distribute the mrna based vaccine. Still need to see what Dr. Coombs and others find with respect to MOA and how a PDT vaccine would work? Yet I feel Covid ...more  
Comment by enriquesuave on Nov 14, 2020 6:52pm
The next few weeks may be pretty exciting indeed.  Next year may be Huge.  IMO.  I'm expecting FDA Fast Track any day, TMO news as well.  New patients treated would be most welcome in advancement of PH2.  Any data on second animal model company has been working on for Preclinical GBM and NSCLC using X- ray activation could also propel our SP significantly. Dr Coombs ...more  
Comment by enriquesuave on Nov 14, 2020 6:55pm
Government Funding would also be the way to go forward with developing TLD-1443 for viruses.  IMO
Comment by Rumpl3StiltSkin on Nov 15, 2020 9:04am
Good points Sir, Seems if anyone could get TLT the gov't funding it is Dr. Coombs. And maybe there will be a lil extra money for the cancers.
Comment by radared on Nov 15, 2020 7:17pm
Suave: also of great value for the investor and to whom it may concern. You want to take into consideration the fact that some or all of the first people treated for cancer may have never tested positive (and never will?) for the c19. News of this nature would necessarily be of importance and indicative of the approach and methods.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250